DHR vs GS: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and The Goldman Sachs Group, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Danaher Corporation · Healthcare
$177.17
+8.9% upside to fair value
Grade B
High Quality
VS
The Goldman Sachs Group, Inc. · Financial Services
$1,096.56
-45.0% upside to fair value
Grade C
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+8.9%).
GS trades at a lower forward P/E
(19.8x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
GS |
| Current Price |
$177.17 |
$1,096.56 |
| Fair Value Estimate |
$192.90 |
$603.11 |
| Upside to Fair Value |
+8.9%
|
-45.0%
|
| Market Cap |
$125.4B |
$323.5B |
| Forward P/E |
34.1x
|
19.8x
|
| EV / EBITDA |
20.8x
|
42.8x
|
| Price / Sales |
5.1x
|
2.9x
|
| Price / FCF |
23.7x
|
-7.7x
|
| Revenue Growth YoY |
+3.7%
|
-45.4%
|
| Gross Margin |
60.7%
|
55.5%
|
| Operating Margin |
21.0%
|
20.5%
|
| Return on Equity |
7.1%
|
14.6%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.22%
|
—
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specializing in medical diagnostics and research tools through three balanced platforms: Biotechnology, Life Sciences, and Diagnostics. The company benefits from a durable competitive moat supported by the Danaher Business System, disciplined capital allocation, and a platform-centric organizational structure. Despite modest revenue growth of…
The Goldman Sachs Group, Inc. operates as a leading global financial services firm with a strong presence in investment banking, global markets, and asset and wealth management. The company benefits from a durable competitive moat based on scale, brand, client relationships, and technology infrastructure. However, recent financial data shows a significant 45.4% year-over-year revenue decline in t…
Accumulation Zones
| Metric |
DHR |
GS |
| Zone Low |
$144.68 |
$452.33 |
| Zone High |
$163.97 |
$512.64 |
| In Buy Zone? |
No
|
No
|